Xvivo Perfusion Ab Stock Return On Asset
| XVIVO Stock | SEK 451.50 5.50 1.23% |
Xvivo Perfusion AB fundamentals help investors to digest information that contributes to Xvivo Perfusion's financial success or failures. It also enables traders to predict the movement of Xvivo Stock. The fundamental analysis module provides a way to measure Xvivo Perfusion's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xvivo Perfusion stock.
Xvivo |
Xvivo Perfusion AB Company Return On Asset Analysis
Xvivo Perfusion's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Xvivo Perfusion Return On Asset | 0.0057 |
Most of Xvivo Perfusion's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xvivo Perfusion AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Xvivo Perfusion AB has a Return On Asset of 0.0057. This is 100.07% lower than that of the Health Care Equipment & Supplies sector and 100.03% lower than that of the Health Care industry. The return on asset for all Sweden stocks is 104.07% lower than that of the firm.
Xvivo Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xvivo Perfusion's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xvivo Perfusion could also be used in its relative valuation, which is a method of valuing Xvivo Perfusion by comparing valuation metrics of similar companies.Xvivo Perfusion is currently under evaluation in return on asset category among its peers.
Xvivo Fundamentals
| Return On Equity | 0.0136 | |||
| Return On Asset | 0.0057 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 5.54 B | |||
| Shares Outstanding | 29.83 M | |||
| Shares Owned By Insiders | 12.25 % | |||
| Shares Owned By Institutions | 54.00 % | |||
| Price To Earning | 662.55 X | |||
| Price To Book | 4.23 X | |||
| Price To Sales | 16.58 X | |||
| Revenue | 258.39 M | |||
| Gross Profit | 296.96 M | |||
| EBITDA | 39.2 M | |||
| Net Income | 8.15 M | |||
| Cash And Equivalents | 398.7 M | |||
| Cash Per Share | 7.45 X | |||
| Total Debt | 1.52 M | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 4.69 X | |||
| Book Value Per Share | 47.94 X | |||
| Cash Flow From Operations | (12.06 M) | |||
| Earnings Per Share | 0.99 X | |||
| Target Price | 383.33 | |||
| Number Of Employees | 133 | |||
| Beta | 1.97 | |||
| Market Capitalization | 7.48 B | |||
| Total Asset | 1.54 B | |||
| Retained Earnings | 22 M | |||
| Working Capital | 81 M | |||
| Current Asset | 98 M | |||
| Current Liabilities | 17 M | |||
| Net Asset | 1.54 B |
About Xvivo Perfusion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xvivo Perfusion AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xvivo Perfusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xvivo Perfusion AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xvivo Stock Analysis
When running Xvivo Perfusion's price analysis, check to measure Xvivo Perfusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xvivo Perfusion is operating at the current time. Most of Xvivo Perfusion's value examination focuses on studying past and present price action to predict the probability of Xvivo Perfusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xvivo Perfusion's price. Additionally, you may evaluate how the addition of Xvivo Perfusion to your portfolios can decrease your overall portfolio volatility.